P47580 AF NFT

Uncharacterized lipoprotein MG338

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeihwfc2iutppo26qkizg6gagrrtkvjrjlh3irp7fabqozjfrhllwpa/metadata.json
IPFS of structure file: 
bafybeifvcggjzqn5ptgaxl7n46vc3ixuiz2njopguipwlivwxgbwc3xqz4/AF-P47580-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9e5E98E011361C5888c92e2CDb7652E02Bd5C7Ed
First NFT owner address (bech32): 
genesis1ne0f3cq3xcw93zxf9ckdkajjuq4at3ldwq49kv
Current NFT ID #515235 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
515235
Accession (UniProt):
P47580
Name::
Uncharacterized lipoprotein MG338
Experimental Method:
Predicted structure
Sequence source:
MYCOPLASMA GENITALIUM (STRAIN ATCC 33530 / G-37 / NCTC 10195)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P47580 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P47580|Y338_MYCGE Uncharacterized lipoprotein MG338 OS=Mycoplasma genitalium (strain ATCC 33530 / G-37 / NCTC 10195) OX=243273 GN=MG338 PE=3 SV=2 MAHRFKRWSLIALAFSGVGATAIITACSTINTANLFPTLNRSQKLIGFSDQNIINPDVVLKSALNDGSGVDSILRVSFGSALQKWYQANADRNISNRLKIFEENVEDEHDNLIDEKKRADRVKWPIEVQKEYDQFGGNQESWKKLKLYDRLITDFQSLIFNNISANVSLVNSSDTSVATTKENIEKTENKLKFINSNLNDVNGDFFTNLQAYLFSQWLIEENPFLLNQASFNYQSPIAGLGSIYDENAIGASNLNLSYNFPAFQDPSESGGQTNSAKLFEEFDKQLQTANSSGSSQSSAATNTRNDLLDFENKYSASKVLISKNNILSVLKTVNLSAAVIDQYHYLLNNKTELTTTTTTTTTTGGTSSNLNPLDKFIKSSSATTVMMKSAMTKSQEVTSDNNGFNVKSEFLKINPSLSSSGSDNSSNTQSFWKQVQALNNSSQTATIFDAVRMESNSSQAQVVTSNLLVSLSSKTTQKQQQKPVYVRGDDAIYAFHIDGGNYFLENSSPNKRNFEKQAEVLLMRFLQGQTNNFSKDNVSFSVDLFGSNSEFRSWANRNTTLKLYTALTTMLENGTSNNNGQKDVCDLAKKLLKNNTNLSETIKKQQDFNNSLSQIKSSYESYIKAANKLNNFRTDLANIEKLEQAIVDRANNYIKLQKEAKESSIGWGQPLPYKRANDGSYPSLAKFFNNNSDQSSAQTLTLKTTAAAITSDNEPTREKNNQTLKTLTTEVENKAKELVEKWKATTYSSSQYSEIITLKSSQLNDLDLDLILSLLTDSGIRTGTVANIFKNWYFKNTNSFTNNFDTSNKELKGEFSDFNDLVKQALYIRSWQNLTSKERFGYYKDLGSVNSTSTMLQMQNKAAQSHTSSSVNQTLLDLAKKAFEKELEDPNQDAEYKYMRFLQALMWLVKNGAQNYKNLLQQAIPIGTRAFVSWTVGYDKNPSATVSQKTKSSTSSANENPFNRFLQNPNYTQGSEINWFNDKQTPIQPDSLLESENTYRFTDEPFNNSVALSNKSQGSSDKKYFYGFNGLTINSNQSISTASAGLTQQLFNNYGQLITATDKAGALSQYKDKFTLWSLINKTSSDAELNAFGELLHRSVNVDTNNLSRFNSRGEPLISFDNKKKFLLNVVDRLDDLYFHKFEGYVGLSKAANTDGSNTEGYKTVQTVPLTNDSSIQTLSYVIQITNDDVNKISSNWKNNKANSLGLKKEIFMSLLIEQALDEGTQELAFLDLIRENQKQHQREHQQILVGDKRLYDILGQTLAINAKNF